Background
The cell-penetrating peptide derived from the Human immunodeficiency virus-1 transactivator protein Tat possesses the capacity to promote the effective uptake of various cargo molecules across the plasma membrane in vitro and in vivo.
The objective of this study was to characterize the uptake and delivery mechanisms of a novel streptavidin fusion construct, TAT47–57-streptavidin (TAT-SA, 60 kD). SA represents a potentially useful TAT-fusion partner due to its ability to perform as a versatile intracellular delivery vector for a wide array of biotinylated molecules or cargoes.
Results
By confocal and immunoelectron microscopy the majority of internalized TAT-SA was shown to accumulate in perinuclear vesicles in both cancer and non-cancer cell lines. The uptake studies in living cells with various fluorescent endocytic markers and inhibiting agents suggested that TAT-SA is internalized into cells efficiently, using both clathrin-mediated endocytosis and lipid-raft-mediated macropinocytosis. When endosomal release of TAT-SA was enhanced through the incorporation of a biotinylated, pH-responsive polymer poly(propylacrylic acid) (PPAA), nuclear localization of TAT-SA and TAT-SA bound to biotin was markedly improved. Additionally, no significant cytotoxicity was detected in the TAT-SA constructs.
Conclusion
This study demonstrates that TAT-SA-PPAA is a potential non-viral vector to be utilized in protein therapeutics to deliver biotinylated molecules both into cytoplasm and nucleus of human cells.
Whole article: "www.pubmedcentral.nih.gov":[ http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1779780]
Lentiviral vectors appear safe for gene therapy -
First clinical trials with lentiviral vectors find them safe and possibly effective for HIV gene therapy (7.11.2006)
Development of a new bicistronic retroviral vector with strong IRES activity -
Internal Ribosome Entry Site (IRES)-based bicistronic vectors are important tools in today's cell biology (7.6.2006)
Therapeutic short hairpin RNA expression in the liver: viral targets and vectors -
Over 500 million people worldwide are infected with one or more different and unrelated types of human hepatitis virus (6.4.2006)
Design and cloning strategies for constructing shRNA expression vectors. -
Short hairpin RNA (shRNA) encoded within an expression vector has proven an effective means of harnessing the RNA interference (RNAi) pathway in mammalian cells (30.3.2006)
Gene Therapy Progress and Prospects – Vectorology: design and production of expression cassettes in AAV vectors -
Adeno-associated virus (AAV) derived vectors are considered highly eligible vehicles for human gene therapy (2.3.2006)
